HALO logo
halo search icon
ADMA Biologics, Inc.

US$8.56

Price Change Indicator
-0.07 (-0.811%)
ADMA Biologics, Inc.
ADMA · NAS

ADMA Biologics, Inc.

Start Trading ADMA for Free

US$8.56

Price Arrow-0.07 (-0.811%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Capital EfficiencyHALO Consensus ValueHALO ValueHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ADMA Biologics, Inc. Overview

ADMA Health Scores

Short Term

Mean Reversion

Very Strong

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About ADMA

icon
icon

Telephone

1.201.478.5552

icon

Address

465 State Route 17 South, Ramsey, NJ 07446

Description

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

ADMA Price Chart

Key Stats

Market Cap

US$2.00B

PE

30.40

EV/EBITDA

22.3

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7.21 - 22.37

Trade Value (12mth)

US$14,475,090.00

1 week

4.35%

1 month

-19.94%

YTD

-51.73%

1 year

-57.11%

All time high

25.67

Key Fundamentals

EPS 3 yr Growth

-285.10%

EBITDA Margin

39.10%

Operating Cashflow

$50m

Free Cash Flow Return

10.30%

ROIC

29.90%

Interest Coverage

28.10

Quick Ratio

3.70

Other Data

Shares Outstanding (Fully Diluted)

240m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ADMA Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
07 May 26
04 May 26

ADMA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.130.850.62locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.130.810.6locklocklock
Growth
 %locklocklocklock62.1772.6-27.3locklocklock
PE
 XlocklocklocklockN/A21.130.4locklocklock
EV/EBITDA
 XlocklocklocklockN/A28.222.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of ADMA Biologics, Inc. (ADMA:NAS)?
Halo FAQ
The current share price of ADMA Biologics, Inc. (ADMA:NAS) is USD$8.56.
What is the 52-week high share price for ADMA Biologics, Inc. (ADMA:NAS)?
Halo FAQ
The 52-week high share price for ADMA Biologics, Inc. (ADMA:NAS) is USD$22.37.
What is the 52-week low share price for ADMA Biologics, Inc. (ADMA:NAS)?
Halo FAQ
The 52-week low share price for ADMA Biologics, Inc. (ADMA:NAS) is USD$7.21.
What is the dividend yield for ADMA Biologics, Inc. (ADMA:NAS)?
Halo FAQ
ADMA Biologics, Inc. (ADMA:NAS) does not pay a dividend.
What was ADMA Biologics, Inc. (ADMA:NAS) last dividend payment?
Halo FAQ
ADMA Biologics, Inc. (ADMA:NAS) does not pay a dividend.
What is the franking level for ADMA Biologics, Inc. (ADMA:NAS)?
Halo FAQ
ADMA Biologics, Inc. (ADMA:NAS) has a franking level of 0.00%.
In which sector is ADMA Biologics, Inc. (ADMA:NAS) classified?
Halo FAQ
ADMA Biologics, Inc. (ADMA:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for ADMA Biologics, Inc. (ADMA:NAS)?
Halo FAQ
The current P/E ratio for ADMA Biologics, Inc. (ADMA:NAS) is 30.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial